Back to search
Human Papillomavirus (HPV) Vaccination
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Human Papillomavirus (HPV) Vaccination trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Human Papillomavirus (HPV) Vaccination trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This clinical trial compares usual care to interpersonal communication training and vaccination workflow training, alone or in combination, for improving commun…
Human papillomavirus (HPV) causes 35,900 US cancer cases per year, 4,000 deaths, and $4 billion in can In this study, the investigators will conduct a 3-arm clu…
This is a randomized observer-blind placebo-controlled proof-of-concept study with the aim to assess the safety and tolerability, and the immunogenicity of a bi…
The purpose of this study is to determine the provider- and practice-level characteristics that influence the impact of implementation strategies guided by prac…
The current study is an open-label, non-randomized, longitudinal exploratory trial using the licensed Gardasil 9 (9vHPV) vaccine in an off-label context to inve…
The purpose of this study is to examine the impact of a structured educational program based on the Transtheoretical Model (TTM) on HPV knowledge, health belief…
This study will compare the use of informational videos only, personal story videos only, and the combination of both, to see which is most effective in increas…
Human papillomavirus (HPV) vaccination is an effective strategy for preventing HPV-related diseases; however, parental knowledge and vaccination intention may i…